Moderna shares are plunging after cancer vaccine data leaked despite positive results. The disclosure is doing the damage here, and the tape will keep pricing headline risk until management cleans it

What happened: Moderna shares plunged after partial cancer vaccine data leaked ahead of the full release. The complete data, released later Thursday, appeared positive based on Wall Street expectations. Why it matters: The stock fell despite the later positive readout, showing the leaked partial data drove the move rather than the full results. Coverage: 4 outlets in 24h

Moderna shares plunged after partial cancer vaccine data leaked ahead of the full release. The complete data, released later Thursday, appeared positive based on Wall Street expectations.

The stock fell despite the later positive readout, showing the leaked partial data drove the move rather than the full results.